Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 5Withdrawn 4Unknown 3Recruiting 3Terminated 2Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1Breast 1

Conditions

Ulcer 1Neoplasm Metastasis 1Melanoma 1Desmoid Tumors 1Breast Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Electrochemotherapy × Clear all
NCT06660121 2026-05-14

ECT-DESMO

Istituto Ortopedico Rizzoli

Withdrawn
Sarcoma

Desmoid Tumors

NCT03448666 2024-09-23

ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases

European Institute of Oncology

Phase 2 Withdrawn
Dermatologic

Melanoma

NCT01479946 2014-12-09

Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin

Uppsala University Hospital

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT00918593 2011-09-27

Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy

Copenhagen University Hospital at Herlev

Phase 2 Withdrawn
98 enrolled

Neoplasm Metastasis, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡